Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
Abstract A literature review does not provide information about the safety of autologous hematopoietic stem cell transplantation (HSCT) in a recipient who has previously received allogeneic HSCT. We treated a 69‐year‐old woman with diffuse large B cell lymphoma. The patient received autologous stem...
Main Authors: | Osamu Imataki, Shunsuke Yoshida, Tomoya Ishida, Haruyuki Fujita, Makiko Uemura |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-04-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.879 |
Similar Items
-
Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Ardeshir Ghavamzadeh, et al.
Published: (2011-03-01) -
Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Mohammad Jahani, et al.
Published: (2011-01-01) -
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
by: Andrea Bacigalupo, et al.
Published: (2021-05-01) -
Transplant in Diffuse Large B-Cell Lymphoma
by: Guilherme Duffles, et al.
Published: (2022-06-01) -
CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01)